Thank you for participating in our presentation. When you have completed the survey, you will be forwarded to a CE certificate generation page.

Q1Please rate your ability to achieve the Learning Objectives below:
 Not at all Somewhat Mostly Completely
 Identify risks of kidney disease and its consequences in patients with T2DM.   
 Appropriately screen for the presence of CKD in patients with T2DM   
 Initiate evidence-based therapy to slow the progression of kidney disease in patients with T2DM and CKD   
 Become familiar with the mineralocorticoid receptor antagonist and endothelin receptor antagonist under late-phase investigation   
Q2As a result of what you have learned during this program, will you change your practice behaviors?
 Definitely Not Unlikely Not Sure Probably Absolutely
Q5Please rate the following:
 Unsatisfactory Needs Improvement Average Above Average Excellent
 Degree to which educational expectations were met    
 Material was relevant to my practice    
 Effective Faculty Presenter    
 Overall Program    
Q6Did the content contribute valuable information that will assist in improving patient outcomes?
 Strongly Disagree Disagree Neutral Agree Strongly Agree
Q7What was your level of expertise on this topic?
 None Little Some Considerable Extensive
 Before this presentation    
 AFTER this presentation    
Q8Do you believe the activity was fair and balanced, free from commercial influences?
 Yes No
Q9Did the program increase your competence?
 Yes No
Q10Which class of medication is supported by little, if any, evidence demonstrating a cardiovascular benefit in a patient with type 2 diabetes and chronic kidney disease?
Q11Which one of the following is correct regarding screening for kidney dysfunction in adults with type 2 diabetes?
Q12How confident do you feel in your answer to the previous question?
 Not at all confident Somewhat confident Confident Very confident

dividing line